« Return to News | CROs/Service Providers

Omnicare re-brands as Theorem Clinical Research

Thursday, June 16, 2011 10:29 AM

CRO Omnicare Clinical Research, based in King of Prussia, Penn., has re-branded the company under the name Theorem Clinical Research. The brand launch marks the final step in the CRO's separation from its former parent company in a deal that was finalized this spring.

Nautic Partners, a private equity firm based in Providence, R.I., acquired the CRO in April. The deal marked the official the separation of Omnicare Clinical Research from former parent company Omnicare.

It also, the company said, accomplished its most visible step in achieving its long-identified goal: to stand on its own and deliver results the way that clients need.

Under its new name, Theorem Clinical Research will continue to provide clinical trial management, with a continued focus on its core early phase, phase II/III and late phase, and its specialized business units in pharmaceutics, medical device and technical services (biometrics and clinical data management).

"This is 25 years in the making," said Dr. James Pusey, president and CEO of Theorem Clinical Research. “We are now in the driver's seat of our own company.”

Over the last five years the company has completed over 1,500 studies worldwide with more than 337,000 participating patients.

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.